+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Third-party Medical Institutions Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6079155
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Third-party Medical Institutions Market is projected to reach USD 8.07 Billion in 2026. It is expected to continue growing at a CAGR of 8.91%, reaching USD 13.52 Billion by 2032.

Third-Party Medical Institutions: Executive Overview

Third-party medical institutions provide healthcare services outside facilities directly operated by public health systems or primary hospital networks. Their role commonly includes diagnostics, outpatient care, specialist services, rehabilitation, testing, and other contracted or independently delivered functions. Strategic priorities are shaped by patient access, clinical quality, regulatory compliance, workforce availability, interoperability, and financial sustainability rather than by ownership status alone.

Healthcare Delivery Is Shifting Toward Distributed, Integrated Care

The landscape is being reshaped by outpatient migration, preventive care, chronic-disease management, home-based services, ambulatory diagnostics, and partnerships across public and private providers. Patients increasingly expect convenient scheduling, digital communication, transparent service information, and coordinated referrals. Institutions that connect clinical pathways, standardize quality processes, and maintain reliable data exchange are better positioned to support continuity of care while reducing avoidable delays and duplication.

Artificial Intelligence Is Reshaping Operations, Diagnostics, and Patient Engagement

Artificial intelligence is being applied to administrative workflows, appointment coordination, clinical documentation, image and signal interpretation, risk stratification, and patient support. Its value depends on validated performance, representative data, clinician oversight, explainability, cybersecurity, and clear accountability. Leaders should treat AI as a governed capability: define approved use cases, monitor outcomes and bias, protect sensitive information, and ensure that automation augments rather than replaces appropriate professional judgment.

Regional Differences Define Access, Regulation, and Partnership Priorities

In North America, third-party institutions operate within complex payer, accreditation, and interoperability environments, making care coordination and compliance central priorities. Latin America combines growing demand for accessible services with uneven infrastructure, encouraging scalable outpatient models and public-private collaboration. Europe emphasizes patient rights, data governance, cross-border standards, and integration with established health systems. The Middle East is marked by healthcare modernization and investment in specialized capacity, while Africa requires adaptable models that address workforce, infrastructure, affordability, and geographic access constraints. Asia-Pacific presents wide variation in regulation, income, digital maturity, and urbanization, creating opportunities for locally tailored delivery networks and technology-enabled access.

Regional Alliances Influence Standards, Mobility, and Coordinated Delivery

ASEAN institutions must account for varied health systems, regulatory regimes, and cross-border mobility while emphasizing interoperable referral and service models. BRICS members face diverse demographic and infrastructure conditions, making affordability, domestic capability, and scalable technology important themes. The European Union provides a framework for cooperation on patient rights, data protection, and health-system coordination. G7 environments generally place strong emphasis on quality assurance, workforce resilience, innovation governance, and fiscal accountability. GCC markets are associated with health-system transformation, specialist capacity building, and digitally enabled services. NATO members must also consider resilience, emergency preparedness, continuity of essential care, and secure information infrastructure.

Country Conditions Require Distinct Operating and Partnership Models

Australia emphasizes distributed access, rural coverage, and coordination between public and independent providers. Brazil requires attention to regional inequality, regulatory compliance, and affordability. Canada’s institutions operate alongside publicly funded provincial systems, making referral integration and capacity management important. China combines large-scale demand with evolving digital health and regulatory requirements. France, Germany, Italy, and Spain place strong weight on quality, professional standards, and alignment with established national or regional health structures. India’s priorities include affordability, access, workforce scale, and digital connectivity. Japan and South Korea emphasize aging populations, technology adoption, and service efficiency. Mexico faces geographic and access disparities alongside opportunities for coordinated private and public delivery. Russia requires careful attention to regional variation, infrastructure, and regulatory conditions. The United Kingdom emphasizes integration with publicly organized care pathways, while the United States features diverse payer arrangements, high compliance requirements, and strong demand for operational efficiency.

Leadership Priorities for Resilient Third-Party Care Delivery

Industry leaders should first map patient journeys and identify bottlenecks across referral, scheduling, diagnosis, treatment, and follow-up. They should then establish measurable standards for safety, access, clinical outcomes, patient experience, data quality, and workforce performance. Strategic partnerships should be selected for complementary capabilities and governed through clear service-level, privacy, escalation, and accountability arrangements. Investment in interoperable systems, cybersecurity, workforce training, and responsible AI should be sequenced around demonstrable clinical and operational needs. Finally, leaders should maintain scenario plans for regulatory change, supply disruption, cyber incidents, staffing shortages, and sudden shifts in patient demand.

Methodology for a Data-Grounded Executive Assessment

This executive summary uses the supplied market definition-third-party medical institutions-and organizes the assessment around structural changes in healthcare delivery, technology adoption, geographic variation, institutional groupings, and leadership actions. Insights are framed qualitatively and avoid unsupported estimates, market sizing, market shares, and forecasts. The regional, group, and country discussion compares differences in care organization, regulation, access, infrastructure, demographics, digital maturity, and resilience. Any operational decision should be validated with current local legislation, provider-level evidence, clinical guidance, and stakeholder consultation.

Third-Party Institutions Can Strengthen Access Through Governed Integration

Third-party medical institutions are increasingly important contributors to flexible, specialized, and technology-enabled healthcare delivery. Their long-term relevance will depend on the ability to combine patient-centered access with rigorous clinical governance, secure data exchange, workforce development, and effective coordination with public and primary care systems. Institutions that pursue disciplined integration, transparent performance management, and responsible innovation can improve continuity and responsiveness while meeting the distinct requirements of their regions, country systems, and collaborative networks.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Third-party Medical Institutions Market, by Service Type
7.1. Introduction
7.2. Ambulatory Surgery Services
7.3. Diagnostic Imaging Services
7.3.1. Ionizing Imaging
7.3.1.1. CT
7.3.1.2. PET
7.3.1.3. X Ray
7.3.2. Non Ionizing Imaging
7.3.2.1. MRI
7.3.2.2. Ultrasound
7.4. Dialysis Services
7.5. Home Healthcare Services
7.6. Laboratory Services
7.7. Telemedicine Services
8. Third-party Medical Institutions Market, by Delivery Channel
8.1. Introduction
8.2. Home Care
8.3. Inpatient
8.4. Outpatient
9. Third-party Medical Institutions Market, by Ownership Model
9.1. Introduction
9.2. Private For Profit
9.3. Private Non Profit
9.4. Public
10. Third-party Medical Institutions Market, by Payment Model
10.1. Introduction
10.2. Bundled Payments
10.3. Capitation
10.4. Fee For Service
11. Third-party Medical Institutions Market, by End User Type
11.1. Introduction
11.2. Clinics
11.3. Hospitals
11.4. Patients
12. Third-party Medical Institutions Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Third-party Medical Institutions Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Third-party Medical Institutions Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. ACM Global Laboratories
16.2. ARUP Laboratories, Inc.
16.3. BioReference Laboratories, Inc.
16.4. Cerba Research S.A.S.
16.5. Charles River Laboratories International, Inc.
16.6. Eurofins Scientific SE
16.7. ICON Public Limited Company
16.8. Laboratory Corporation of America Holdings
16.9. Myriad Genetics, Inc.
16.10. NeoGenomics Laboratories, Inc.
16.11. PPD, Inc.
16.12. Quest Diagnostics Incorporated
16.13. Sonic Healthcare Limited
16.14. Synlab International GmbH
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Third-party Medical Institutions Market, Years Considered for the Study
FIGURE 2. Global Third-party Medical Institutions Market, Research Design
FIGURE 3. Global Third-party Medical Institutions Market, Research Framework
FIGURE 4. Global Third-party Medical Institutions Market, Data Triangulation
FIGURE 5. Global Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Third-party Medical Institutions Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global Third-party Medical Institutions Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Third-party Medical Institutions Market Size, by Delivery Channel, 2025 vs 2032 (%)
FIGURE 9. Global Third-party Medical Institutions Market Size, by Delivery Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Third-party Medical Institutions Market Size, by Ownership Model, 2025 vs 2032 (%)
FIGURE 11. Global Third-party Medical Institutions Market Size, by Ownership Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Third-party Medical Institutions Market Size, by Payment Model, 2025 vs 2032 (%)
FIGURE 13. Global Third-party Medical Institutions Market Size, by Payment Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Third-party Medical Institutions Market Size, by End User Type, 2025 vs 2032 (%)
FIGURE 15. Global Third-party Medical Institutions Market Size, by End User Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Third-party Medical Institutions Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Third-party Medical Institutions Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Third-party Medical Institutions Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Third-party Medical Institutions Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Third-party Medical Institutions Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Third-party Medical Institutions Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Third-party Medical Institutions Market Segmentation & Coverage
TABLE 2. Global Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 3. Global Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Ambulatory Surgery Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Ambulatory Surgery Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Ambulatory Surgery Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Diagnostic Imaging Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Diagnostic Imaging Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Diagnostic Imaging Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Ionizing Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Ionizing Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Ionizing Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global PET Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global PET Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global PET Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global X Ray Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global X Ray Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global X Ray Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Non Ionizing Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Non Ionizing Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Non Ionizing Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Dialysis Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Dialysis Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Dialysis Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Home Healthcare Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Home Healthcare Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Home Healthcare Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Laboratory Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Laboratory Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Laboratory Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Telemedicine Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Telemedicine Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Telemedicine Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 44. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Inpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Inpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Inpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Outpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Outpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Outpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 54. Global Private For Profit Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Private For Profit Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Private For Profit Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Private Non Profit Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Private Non Profit Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Private Non Profit Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Public Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Public Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Public Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 64. Global Bundled Payments Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Bundled Payments Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Bundled Payments Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Capitation Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Capitation Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Capitation Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Fee For Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Fee For Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Fee For Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 74. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Third-party Medical Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Third-party Medical Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 93. North America Third-party Medical Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. North America Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 95. North America Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 96. North America Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 97. North America Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 98. North America Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 99. North America Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 100. North America Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 101. North America Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 102. Latin America Third-party Medical Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Latin America Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 104. Latin America Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 105. Latin America Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 106. Latin America Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 107. Latin America Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 108. Latin America Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 109. Latin America Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 110. Latin America Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 111. Europe Third-party Medical Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Europe Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 113. Europe Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 114. Europe Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 115. Europe Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 116. Europe Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 117. Europe Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 118. Europe Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 119. Europe Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 120. Middle East Third-party Medical Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Middle East Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 122. Middle East Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 123. Middle East Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 124. Middle East Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 125. Middle East Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 126. Middle East Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 127. Middle East Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 128. Middle East Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 129. Africa Third-party Medical Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Africa Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 131. Africa Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 132. Africa Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 133. Africa Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 134. Africa Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 135. Africa Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 136. Africa Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 137. Africa Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 138. Global Third-party Medical Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. ASEAN Third-party Medical Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. ASEAN Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 141. ASEAN Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 142. ASEAN Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 143. ASEAN Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 144. ASEAN Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 145. ASEAN Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 146. ASEAN Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 147. ASEAN Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 148. GCC Third-party Medical Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. GCC Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 150. GCC Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 151. GCC Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 152. GCC Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 153. GCC Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 154. GCC Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 155. GCC Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 156. GCC Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 157. European Union Third-party Medical Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. European Union Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 159. European Union Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 160. European Union Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 161. European Union Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 162. European Union Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 163. European Union Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 164. European Union Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 165. European Union Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 166. BRICS Third-party Medical Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. BRICS Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 168. BRICS Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 169. BRICS Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 170. BRICS Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 171. BRICS Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 172. BRICS Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 173. BRICS Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 174. BRICS Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 175. G7 Third-party Medical Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. G7 Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 177. G7 Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 178. G7 Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 179. G7 Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 180. G7 Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 181. G7 Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 182. G7 Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 183. G7 Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 184. NATO Third-party Medical Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. NATO Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 186. NATO Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 187. NATO Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 188. NATO Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 189. NATO Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 190. NATO Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 191. NATO Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 192. NATO Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 193. Global Third-party Medical Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 194. United States Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 195. United States Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 196. United States Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 197. United States Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 198. United States Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 199. United States Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 200. United States Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 201. United States Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 202. United States Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 203. Canada Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 204. Canada Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 205. Canada Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 206. Canada Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 207. Canada Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 208. Canada Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 209. Canada Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 210. Canada Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 211. Canada Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 212. Mexico Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 213. Mexico Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 214. Mexico Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 215. Mexico Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 216. Mexico Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 217. Mexico Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 218. Mexico Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 219. Mexico Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 220. Mexico Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 221. Brazil Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 222. Brazil Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 223. Brazil Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 224. Brazil Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 225. Brazil Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 226. Brazil Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 227. Brazil Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 228. Brazil Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 229. Brazil Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 230. United Kingdom Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 231. United Kingdom Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 232. United Kingdom Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 233. United Kingdom Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 234. United Kingdom Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 235. United Kingdom Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 236. United Kingdom Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 237. United Kingdom Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 238. United Kingdom Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 239. Germany Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 240. Germany Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 241. Germany Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 242. Germany Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 243. Germany Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 244. Germany Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 245. Germany Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 246. Germany Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 247. Germany Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 248. France Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 249. France Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 250. France Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 251. France Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 252. France Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 253. France Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 254. France Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 255. France Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 256. France Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 257. Russia Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 258. Russia Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 259. Russia Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 260. Russia Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 261. Russia Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 262. Russia Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 263. Russia Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 264. Russia Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 265. Russia Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 266. Italy Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 267. Italy Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 268. Italy Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 269. Italy Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 270. Italy Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 271. Italy Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 272. Italy Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 273. Italy Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 274. Italy Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 275. Spain Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 276. Spain Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 277. Spain Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 278. Spain Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 279. Spain Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 280. Spain Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 281. Spain Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 282. Spain Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 283. Spain Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 284. China Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 285. China Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 286. China Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 287. China Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 288. China Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 289. China Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 290. China Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 291. China Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 292. China Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 293. India Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 294. India Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 295. India Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 296. India Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 297. India Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 298. India Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 299. India Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 300. India Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 301. India Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 302. Japan Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 303. Japan Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 304. Japan Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 305. Japan Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 306. Japan Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 307. Japan Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 308. Japan Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 309. Japan Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 310. Japan Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 311. Australia Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 312. Australia Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 313. Australia Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 314. Australia Third-party Medical Institutions Market Size, by Ionizing Imaging, 2017-2032 (USD Million)
TABLE 315. Australia Third-party Medical Institutions Market Size, by Non Ionizing Imaging, 2017-2032 (USD Million)
TABLE 316. Australia Third-party Medical Institutions Market Size, by Delivery Channel, 2017-2032 (USD Million)
TABLE 317. Australia Third-party Medical Institutions Market Size, by Ownership Model, 2017-2032 (USD Million)
TABLE 318. Australia Third-party Medical Institutions Market Size, by Payment Model, 2017-2032 (USD Million)
TABLE 319. Australia Third-party Medical Institutions Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 320. South Korea Third-party Medical Institutions Market Size, 2017-2032 (USD Million)
TABLE 321. South Korea Third-party Medical Institutions Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 322. South Korea Third-party Medical Institutions Market Size, by Diagnostic Imaging Services, 2017-2032 (USD Million)
TABLE 323. South K

Companies Mentioned

  • ACM Global Laboratories
  • ARUP Laboratories, Inc.
  • BioReference Laboratories, Inc.
  • Cerba Research S.A.S.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • ICON Public Limited Company
  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • NeoGenomics Laboratories, Inc.
  • PPD, Inc.
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Synlab International GmbH